FBT ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
ALNY	A	0.43	5.25
UTHR	B	-1.90	4.30
CORT	C	-3.36	4.30
HALO	B	1.38	4.22
VRTX	B	-0.74	3.76
ARGX	B	-0.05	3.71
AMGN	B	-0.45	3.70
REGN	B	-1.97	3.67
NTRA	B	0.85	3.67
MRNA	D	-0.96	3.64
BIIB	C	-1.84	3.64
INCY	C	-2.30	3.59
MTD	C	-0.22	3.52
ITCI	C	0.77	3.40
BGNE	F	2.81	3.25
GILD	C	-2.65	3.19
NBIX	C	0.54	3.15
ALKS	D	0.17	3.14
EXEL	C	-0.86	3.12
CPRX	D	-3.10	3.12
ACAD	D	-1.58	3.01
BNTX	F	1.40	2.93
BEAM	D	4.03	2.92
BMRN	D	-1.51	2.86
WAT	F	1.06	2.80
GMAB	F	1.00	2.76
ILMN	F	-0.22	2.71
RGEN	F	0.52	2.33
BRKR	F	0.31	2.31
EXAS	F	0.05	1.97

Represented by ETF Holdings

Keywords: Biotechnology Biopharmaceutical Medicine S&P 500 Cancer Nasdaq 100 Disorders Inflammation Life Sciences Monoclonal Antibodies Monoclonal Antibody Chemical Compounds Diabetes Immunology Lymphoma Pain Schizophrenia Solid Tumors Acute Myeloid Leukemia Alcohol

Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities

Recent News for First Trust Amex Biotech Index Fund & its Holdings

Date	Stock	Title
Jul 3	AMGN	S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3	AMGN	Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
Jul 3	REGN	Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3	NTRA	Natera (NTRA) Soared After a 43% Increase In Revenue
Jul 3	BRKR	Bruker (BRKR) Expands in NMR Spectrometry With New FMP Collab
Jul 3	REGN	Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Jul 3	BNTX	GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Jul 3	HALO	How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
Jul 3	MRNA	Tesla Deliveries Surprised. 3 Ways Elon Musk Can Drive the Stock Forward and a Few Other Things to Know Today.
Jul 3	NTRA	Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
Jul 3	REGN	Sanofi, Regeneron win EU label expansion for Dupixent in COPD
Jul 3	NTRA	Natera's (NASDAQ:NTRA) investors will be pleased with their massive 314% return over the last five years
Jul 3	GILD	5 FDA decisions to watch in the third quarter
Jul 3	NTRA	Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA)
Jul 3	MRNA	Moderna’s mRNA influenza vaccine receives $176m boost
Jul 3	MRNA	Moderna Stock (NASDAQ:MRNA): Next-Gen COVID-19 Vaccine Is More Than a Rehash
Jul 3	REGN	Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
Jul 2	REGN	Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
Jul 2	INCY	S&P 500 Gains and Losses Today: Index Tops 5,500 as Powell Touts Inflation Progress
Jul 2	BIIB	Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.
Exchange Traded Fund ETF Index Fund Stock Market Index Biotechnology

ETF Components for FBT - First Trust Amex Biotech Index Fund